|
| 37949350 | Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities. | Transl Res | 2024 |
| 37916971 | Translational Aspects of Epithelioid Sarcoma: Current Consensus. | Clin Cancer Res | 2024 |
| 36928072 | The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers. | PLoS One | 2023 |
| 37625197 | Corrigendum to 'Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up': [ESMO Open 7(6):100602, December 2022]. | ESMO Open | 2023 |
| 37781187 | Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure. | Front Oncol | 2023 |
| 37573683 | EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report. | Oral Oncol | 2023 |
| 37499377 | Direct and indirect effects of COVID-19 on short-term mortality of breast cancer patients. | Breast | 2023 |
| 37384065 | Epidemiology of rare cancers in India and South Asian countries - remembering the forgotten. | Lancet Reg Health Southeast Asia | 2023 |
| 36753992 | Cancer burden in adolescents and young adults in Europe. | ESMO Open | 2023 |
| 36780834 | Increased incidence of rare cancers and varied age distributions by cancer group: A population-based cancer registry study in Hiroshima Prefecture, Japan. | Cancer Epidemiol | 2023 |
| 36845700 | Cancer treatment data available in European cancer registries: Where are we and where are we going? | Front Oncol | 2023 |
| 36540941 | Developing a comorbidity score in cancer patients using healthcare utilization databases during the COVID-19 pandemic: An experience from Italy. | Cancer Med | 2023 |
| 34560242 | Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2022 |
| 35704342 | COVID-19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020. | Int J Cancer | 2022 |
| 35852078 | [The problem of rare cancers.] | Recenti Prog Med | 2022 |
| 36567082 | Salivary gland cancer: ESMO-European Reference Network on Rare Adult Solid Cancers (EURACAN) Clinical Practice Guideline for diagnosis, treatment and follow-up. | ESMO Open | 2022 |
| 36419883 | Editorial: Real-World evidence in onco-hematological patients. | Front Oncol | 2022 |
| 36374643 | Is rare cancer care organized at national health system level? Multiple case study in six EU countries. | Eur J Public Health | 2022 |
| 36340999 | Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Survivorship Care Working Group. | Cancer Manag Res | 2022 |
| 36031697 | Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments. | Cancer Treat Rev | 2022 |
| 36184796 | Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort. | Pediatr Blood Cancer | 2022 |
| 35131451 | 'Rare cancers': not all together in clinical studies! | Ann Oncol | 2022 |
| 35121086 | A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry. | J Thorac Oncol | 2022 |
| 34582036 | Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort. | Cancer | 2022 |
| 34718388 | Estimating Country-Specific Incidence Rates of Rare Cancers: Comparative Performance Analysis of Modeling Approaches Using European Cancer Registry Data. | Am J Epidemiol | 2022 |
| 32893942 | Where are adolescents with cutaneous melanoma treated? An Italian nationwide study on referrals based on hospital discharge records. | Pediatr Blood Cancer | 2021 |
| 33910263 | Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities. | Cancer | 2021 |
| 33751795 | Complexity index in sarcoma and genomic grade index gene signatures in rhabdomyosarcoma of pediatric and adult ages. | Pediatr Blood Cancer | 2021 |
| 34500044 | Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. | Ann Oncol | 2021 |
| 34574895 | Analysis of the Consumption of Non-Oncological Medicines: A Methodological Study on Patients of the Ada Cohort. | Healthcare (Basel) | 2021 |
| 34303806 | Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>â¿¿</sup>. | Ann Oncol | 2021 |
| 34272262 | Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 34090171 | Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts. | ESMO Open | 2021 |
| 34139485 | European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN. | ESMO Open | 2021 |
| 33107152 | Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project. | Head Neck | 2021 |
| 33358989 | Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>â¿ </sup>. | Ann Oncol | 2021 |
| 33385768 | Kaposi sarcoma incidence, survival and trends: Data from the information network on rare cancers in Europe (RARECAREnet). | Cancer Epidemiol | 2021 |
| 32758055 | Impact of Rhabdomyosarcoma Treatment Modalities by Age in a Population-Based Setting. | J Adolesc Young Adult Oncol | 2021 |
| 32220947 | Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU). | ESMO Open | 2020 |
| 31660779 | Where Are Adolescents with Soft Tissue Sarcomas Treated? An Italian Nationwide Study on Referrals Based on Hospital Discharge Records. | J Adolesc Young Adult Oncol | 2020 |
| 33209614 | <i>SMO</i> mutations confer poor prognosis in malignant pleural mesothelioma. | Transl Lung Cancer Res | 2020 |
| 33066161 | Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients. | Cancers (Basel) | 2020 |
| 33091381 | Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience. | Cancer Cell | 2020 |
| 32770690 | Cardiovascular Risk After Adjuvant Trastuzumab in Early Breast Cancer: An Italian Population-Based Cohort Study. | Oncologist | 2020 |
| 33018191 | Methodology and technology for the development of a prognostic MRI-based radiomic model for the outcome of head and neck cancer patients. | Annu Int Conf IEEE Eng Med Biol Soc | 2020 |
| 32619051 | Reply to Incidence of extrameningeal solitary fibrous tumors and Novel therapeutic approaches in the treatment of solitary fibrous tumors: A call for a combination therapy. | Cancer | 2020 |
| 32901932 | A system for classifying cancers diagnosed in adolescents and young adults. | Cancer | 2020 |
| 32947429 | Resolution of Citalopram Sexual Adverse Effects With Low Dose of Cariprazine: A Case Report. | Clin Neuropharmacol | 2020 |
| 32721181 | Immunometabolic Status of COVID-19 Cancer Patients. | Physiol Rev | 2020 |
| 32364316 | Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population-based nationwide study. | Thorac Cancer | 2020 |